Latest Security News

Sovereign Metals has marked significant progress at its Kasiya Rutile-Graphite Project in Malawi, completing key geotechnical studies and securing a power supply framework. New US tariffs on Chinese graphite elevate Kasiya’s strategic importance as a low-cost alternative.

NEXION Group Ltd has exited a major transaction, sold its Perth data centre, and relaunched its AI-focused subsidiary, positioning itself for renewed growth and ASX reinstatement.

ImpediMed Limited reported a record quarter for its SOZO device sales with $6.3 million in contracts, supported by expanded US reimbursement coverage and new funding. Despite stable revenue, the company’s cost-cutting and strategic moves position it well for growth in FY26.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir ahead of schedule, setting sights on expedited FDA approval leveraging the Animal Rule.

Juno Minerals has agreed to sell its Mount Mason DSO Hematite Project for A$6 million cash plus a 2% royalty, while maintaining focus on its flagship Mount Ida Magnetite Project. The transaction strengthens Juno’s cash position and sets the stage for renewed development efforts.

Battery Age Minerals has initiated its maiden drilling campaign at the Bleiberg Zinc-Germanium Project following regulatory approval, while advancing exploration at El Aguila with a $3 million capital raise backing its growth.

Knosys Limited sustains a robust $9.8 million Annual Recurring Revenue, extends its ANZ Bank contract, and accelerates AI-driven library technology development with promising early market feedback.

FireFly Metals reports exceptional drilling results at its Green Bay Copper-Gold Project, extending mineralisation well beyond current resources. Backed by a substantial A$145 million capital raise, the company is poised for a resource update and advancing mining studies.

Black Dragon Gold progresses its Salave Gold Project’s strategic investment application amid positive community support and reports a stable cash position at quarter-end.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology candidate, completed FDA IND transfer, and plans to launch phase II trials in 2026. The company also reported a solid cash position and issued loyalty options to shareholders.

Peppermint Innovation Ltd reported robust growth in registered users, loan approvals, and transaction volumes in its June 2025 quarter, alongside strategic partnerships and key platform upgrades aimed at expanding financial inclusion in the Philippines.

Nex Metals Explorations has moved closer to finalising a joint project agreement for its Kookynie Tailings Project while navigating leadership changes and securing fresh capital to fund growth.